A new study headed by teams at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), and Open Targets has indicated how mutations that cause cancer drug resistance fall ...
Ozempic and similar weight-loss medications are hailed as miracle drugs. But there are plenty of unknowns about long-term use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results